Author:
Vicente-Baz David,Paredes Alfredo,Morán Teresa,Massuti Bartomeu,Reguart Noemí,Álvarez Rosa,Insa Amelia,Juan-Vidal Oscar,Artal Ángel,Esteban Emilio,García-Campelo Rosario,Ortega-Granados Ana L.,Diz Pilar,González-Larriba Jose L.,Terrasa Josefa,de las Peñas Ramón,Rodríguez-Abreu Delvys,Callejo Ángel,Márquez Gloria,Provencio Mariano
Subject
Pathology and Forensic Medicine
Reference26 articles.
1. American Cancer Society. Key statistics for lung cancer. Available from: https://www.cancer.org/cancer/non-small-cell-lung-cancer/about/key-statistics.html. [Accessed 17 October 2017].
2. Cancer treatment and survivorship statistics, 2016;Miller;CA Cancer J Clin,2016
3. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII);Midha;Am J Cancer Res,2015
4. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009
5. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial;Rosell;Lancet Oncol,2012
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献